1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Autoimmune Disease Diagnostic Market Size Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis

Autoimmune Disease Diagnostic Market Size Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis

  • November 2021
  • 118 pages
  • ID: 6187073
  • Format: PDF
  • Renub Research

Summary

Table of Contents

Autoimmune Disease Diagnostic Market Size Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis

Autoimmune diseases arise when the immune system fails to recognize the body’s tissues and cells as "self" and alternatively mounts an immune response against the tissues, considering them foreign bodies.
Depending on the type of illness a person has, autoimmune conditions can influence different body areas and upset the average growth and development of organs. According to American Autoimmune Related Diseases Association (AARDA), there are as many as 80 autoimmune disorders. Many of them have similar symptoms, and it is also possible to have more than one simultaneously. Autoimmune diseases ordinarily fluctuate intervening periods of remission (little or no symptoms) and flare-ups (worsening symptoms). According to the research, Global Autoimmune Diseases Diagnostic Market will be US$ 8.02 Billion by 2027.

Autoimmune Disease Diagnosis and Treatment Drives the Market
In autoimmune disease diagnostics, the autoantibody screening is acting as a medium to diagnose and monitor levels further to predict the progression of the disease. However, vague and slow to exhibit signs and symptoms present may mislead during analysis. Some of the more common symptoms of autoimmune disorders include fatigue, general feeling of being unwell (malaise), dizziness, joint pain, rash, and low-grade fever. Hence, laboratory tests are performed to diagnose autoimmune disorders depending on the particular condition the health practitioner suspects a person is suffering from. Besides, tests usually include blood tests for one or more auto antibodies. Tests for inflammation include such as C-reactive protein (CRP, the preferred test) and erythrocyte sedimentation rate (ESR).

Worldwide Autoimmune Diseases Diagnostics Industry will grow with a CAGR of 8.41% during 2021 to 2027

By Type, Systemic Autoimmune Diseases and Localized Autoimmune Disease Diagnostics are two significant types of Autoimmune Disease Diagnostic. Wherein, systemic autoimmune diseases are a broad range of related diseases characterized by dysregulation of the immune system, which activates immune cells to attack autoantigens and results in inappropriate inflammation and multi-tissue damages. Moreover, vital organs such as lung and kidney involvement in systemic autoimmune diseases are common and always presented in a progressive pattern with limited treatment strategy, making them be one of the most common causes of death in patients. These diseases are frequently conducted by clinical immunology/allergy specialists and rheumatologists.

Whilst localized (organ-specific) autoimmune diseases mainly affect a single organ or tissue. The effects frequently extend to other body systems and organs. Moreover, these diseases are often managed by organ-specific medical specialists, such as endocrinologists, gastroenterologists, neurologists or rheumatologists. As per our analysis, the market shares of Localized Autoimmune Disease Diagnostics are expected to be dominant throughout the forecast period.

Thyroiditis and Rheumatoid Arthritis top two amongst the most Common Autoimmune Diseases
By disease, the market is segmented into Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren’s Syndrome and Scleroderma. As per our analysis, Thyroiditis and Rheumatoid Arthritis are the top two most common autoimmune diseases. Wherein thyroiditis have the highest market share as per our estimation which deals with the inflammation of the thyroid gland. Many etiologists of thyroiditis involve silent or subclinical thyroiditis, transient hyperthyroidism, acute and subacute infectious thyroiditis, and chronic autoimmune thyroiditis. Thyroid function examinations are used to strengthen thyroid disease, depending on results, and thyroid antibody tests may be considered to ensure an autoimmune cause of thyroiditis. Antithyroid antibody tests include tests for thyroid peroxidase (TPO) autoantibodies (TPOAb), thyroid-stimulating hormone (TSH) receptor autoantibodies (TRAb), and thyroglobulin (Tg) autoantibodies (TgAb).

Similarly, Rheumatoid arthritis standing second in the market share is a chronic joint disease that weakens the body’s joints. It is also a systemic disease that potentially affects the body’s internal organs and leads to disability. Rheumatoid arthritis is the most prevalent form of autoimmune, inflammatory arthritis in adults. It can also affect children. Therefore, the current approach is to treat rheumatoid arthritis aggressively with DMARDs (disease-modifying antirheumatic drugs) soon after diagnosis. Treating rheumatoid arthritis begins, within three to 12 months after indications begin, is the most excellent way to stop or slow the rise of the disease and bring about remission. Also, ongoing (long-term) treatment with combinations of medications may offer most people the best control and prognosis of rheumatoid arthritis.

Hospitals and Clinical Laboratories have well-established market share for Evaluating a Patient with a Suspected Autoimmune Disease
By End Users, the Autoimmune Disease Diagnostics Industry revolves around two main realms, namely Hospitals and Clinical Laboratories. Hospitals and Clinical Laboratories have well-established market share for evaluating a patient with suspected autoimmune disease. The results can strengthen a diagnosis, assess disease severity, aid in determining prognosis and are helpful to follow disease activity. Remarkably, the hospital and clinical laboratory examination components include complete blood count with differential, comprehensive metabolic panel, inflammatory markers, autoantibodies, and flow cytometry.

Regional Analysis: Global Autoimmune Disease Diagnostics Market Size was US$ 4.94 Billion in 2021

Based on Region, The Global Autoimmune Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and Latin America. As per our analysis, in Europe, the rising incidences of chronic diseases, the increasing geriatric population are the major factors spurring the autoimmune disease diagnosis industry growth, making it the most dominant in the market. Moreover, the Asia-Pacific is expected to show extensive market growth during the forecast period, owing to increasing disposable income and the growing patient pool in developing countries.

Cumulative Impact of COVID-19 on Autoimmune Disease:

Globally, the patients suffering from autoimmune disease feared the COVID-19 had severe adverse reactions or that the autoimmune condition may worsen amidst the pandemic. Consequently, these patients could be at a higher risk of severe COVID-19. Hence, the health providers working consistently for the patients promoted regular autoimmune disease diagnosis booming the industry growth.

Competitive Landscape booming the Global Autoimmune Disease Diagnostics Market:

Global Autoimmune Disease Diagnostics Market has the presence of many regional players who have many outlooks in emerging countries operating at regional or country-level with expertise and experience comprises the number of players functioning in the segment for years. Some of the significant players performing in the Autoimmune Disease Diagnostics Market are Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA.

Further, these multi-national companies are developing products primarily for the autoimmune disease diagnosis segment to address the growing healthcare concerns regarding this disease. For instance, in March 2021, Roche launched Cobas pure integrated solutions analyzer to help simplify operations in small to medium-sized labs. Similarly, in May 2021, Siemens Healthineers also launched a new CT scanner for fast diagnosis and precise interventions in demanding clinical areas.

This latest report “Autoimmune Disease Diagnostic Market, Global Forecast By Type ( Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics), Disease (Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren’s Syndrome, Scleroderma and Others), End Users (Hospitals, Clinical Laboratories and Others), Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America), Companies (Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA)” provides a detailed analysis of Autoimmune Disease Diagnostic Industry.

Type – Autoimmune Disease Diagnostic Market have been covered from 2 viewpoints:
1. Systemic Autoimmune Disease Diagnostics
2. Localized Autoimmune Disease Diagnostics

Disease – Autoimmune Disease Diagnostic Market have been covered from 6 viewpoints:
1. Systemic Lupus Erythematosus
2. Thyroiditis
3. Rheumatoid Arthritis
4. Sjögren’s Syndrome
5. Scleroderma
6. Others

End Users – Autoimmune Disease Diagnostic Market have been covered from 3 viewpoints:
1. Hospitals
2. Clinical Laboratories
3. Others

Region – Autoimmune Disease Diagnostic Market have been covered from 5 viewpoints:
1. North America
2. Europe
3. Asia Pacific
4. Middle East & Africa
5. Latin America

Company Insights:
• Overview
• Recent Development & Strategies
• Financial Insights

Company Covered:
1. Abbott Laboratories
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Siemens Healthineers
5. bioMerieux SA

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Ankylosing Spondylitis Market Research Report by Drug, by Type of Molecule, by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • January 2022
  • 218 pages

Ankylosing Spondylitis Market Research Report by Drug (Cimzia, Cosentyx, and Enbrel), by Type of Molecule (Biologics and Small Molecules), by Mechanism Of Action, by Route Of Administration, by Dosage ...

  • World
  • Autoimmune Disease
  • Marketing Research
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on